Ftse Mib
34.375,92
0,00%
DAX
18.590,89
-0,95%
S&P 500
5.631,22
0,28%
NASDAQ
18.472,57
0,40%
Bitcoin
63.879,47
-1,50%
Registration Strip Icon for default Registrati gratuitamente per ottenere quotazioni in tempo reale, grafici interattivi, flusso di opzioni in tempo reale e altro ancora.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Adicet Bio Inc (ACET) Adicet Bio Inc (ACET) Notizie

ACET

Adicet Bio (ACET)

HOME News News di Agenzia

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:ACET
DataOraFonteTitoloSimboloCompagnia
13/04/202113:00GlobeNewswire Inc.Adicet Bio Appoints Dr. Blake Aftab as Vice President of ResearchNASDAQ:ACETAdicet Bio Inc
09/04/202122:33Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ACETAdicet Bio Inc
08/04/202122:37Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ACETAdicet Bio Inc
02/04/202100:44Edgar (US Regulatory)Amended Statement of Changes in Beneficial Ownership (4/a)NASDAQ:ACETAdicet Bio Inc
18/03/202122:26Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:ACETAdicet Bio Inc
17/03/202100:06Edgar (US Regulatory)Amended Statement of Beneficial Ownership (3/a)NASDAQ:ACETAdicet Bio Inc
12/03/202112:27Edgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)NASDAQ:ACETAdicet Bio Inc
11/03/202122:10GlobeNewswire Inc.Adicet Reports Fourth Quarter and Full Year 2020 Financial Results and Provides Business UpdateNASDAQ:ACETAdicet Bio Inc
10/03/202113:00PR Newswire (US)Adicet Bio Announces Initiation of its First-in-Human Phase 1 Trial of ADI-001 for the Treatment of B Cell Non-Hodgkin's Lymp...NASDAQ:ACETAdicet Bio Inc
08/03/202114:30Edgar (US Regulatory)Statement of Beneficial Ownership (sc 13d)NASDAQ:ACETAdicet Bio Inc
08/03/202114:15Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:ACETAdicet Bio Inc
04/03/202122:01GlobeNewswire Inc.Adicet Bio Appoints Dr. Andrew Sinclair to its Board of DirectorsNASDAQ:ACETAdicet Bio Inc
23/02/202122:06Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:ACETAdicet Bio Inc
16/02/202113:00GlobeNewswire Inc.Adicet Bio, Inc. Announces Closing of $152 Million Public Offering and Concurrent Private Placement and Exercise in Full of t...NASDAQ:ACETAdicet Bio Inc
11/02/202123:22Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)NASDAQ:ACETAdicet Bio Inc
11/02/202113:00GlobeNewswire Inc.Adicet Bio to Participate in Upcoming Investor ConferencesNASDAQ:ACETAdicet Bio Inc
10/02/202113:51GlobeNewswire Inc.Adicet Bio, Inc. Announces Pricing of $135 Million Public Offering of Common Stock and Concurrent Private PlacementNASDAQ:ACETAdicet Bio Inc
10/02/202113:39Edgar (US Regulatory)Registration of Additional Securities (up to 20%) (s-3mef)NASDAQ:ACETAdicet Bio Inc
09/02/202122:04GlobeNewswire Inc.Adicet Bio, Inc. Announces Proposed Public Offering of Common Stock and Concurrent Private PlacementNASDAQ:ACETAdicet Bio Inc
08/12/202013:00GlobeNewswire Inc.Adicet Bio to Participate in Fireside Chat at JMP Securities Hematology SummitNASDAQ:ACETAdicet Bio Inc
03/12/202019:02Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:ACETAdicet Bio Inc
01/12/202013:00GlobeNewswire Inc.Adicet Announces Appointment of Dr. Bastiano Sanna to its Board of DirectorsNASDAQ:ACETAdicet Bio Inc
05/11/202023:20Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:ACETAdicet Bio Inc
05/11/202022:10GlobeNewswire Inc.Adicet Reports Third Quarter 2020 Financial Results and Provides Business UpdateNASDAQ:ACETAdicet Bio Inc
29/10/202023:42Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:ACETAdicet Bio Inc
26/10/202021:10GlobeNewswire Inc.Adicet Appoints Don Healey, Ph.D., as Chief Technology OfficerNASDAQ:ACETAdicet Bio Inc
22/10/202013:00GlobeNewswire Inc.Adicet Announces FDA Clearance of IND Application for First-in-Class Allogeneic CAR Gamma-Delta T Cell TherapyNASDAQ:ACETAdicet Bio Inc
01/10/202022:32Edgar (US Regulatory)Amended Current Report Filing (8-k/a)NASDAQ:ACETAdicet Bio Inc
01/10/202022:10GlobeNewswire Inc.Adicet Bio to Present at the Jefferies Cell Therapy SummitNASDAQ:ACETAdicet Bio Inc
23/09/202004:41GlobeNewswire Inc.Adicet Bio, Inc. Determines Not to Proceed with Public Offering of Common StockNASDAQ:ACETAdicet Bio Inc
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:ACET

La tua Cronologia

BIT
11COV
Covestro
BIT
18TRA
Traton
BIT
19MW
Marvell Technology
BIT
1A
Agilent Technologies
BIT
1AA
Alcoa
BIT
1AAD
Amadeus Fire
BIT
1AAG
Aumann
BIT
1AAL
American Airlines
BIT
1AAPL
Apple
BIT
1ABBV
Abbvie
BIT
1ABI
Anheuser Busch InBev SA NV
BIT
1ABNB
Airbnb
BIT
1ACA
Credit Agricole
BIT
1ACS
ACS Actividades de Const...
BIT
1AD
Koninklijke Ahold Delhai...
BIT
1ADBE
Adobe
Delayed Upgrade Clock
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network